Real-world demographic and clinical profiles of patients with treatment-resistant depression initiated on esketamine nasal spray-Reference-Cited by-同舟云学术

Real-world demographic and clinical profiles of patients with treatment-resistant depression initiated on esketamine nasal spray

Published:2024-09-02 Issue: Volume: Page:1-11
ISSN:1365-1501
Container-title:International Journal of Psychiatry in Clinical Practice
language:en
Short-container-title:International Journal of Psychiatry in Clinical Practice

Author:

Samalin Ludovic¹,Mekaoui Lila²,De Maricourt Pierre³,Sauvaget Anne⁴,Codet Marie-Alix⁵,Gaudré-Wattinne Émeline⁵,Wicart Clotilde⁵,Rothärmel Maud⁶

Affiliation:

1. CHU Clermont-Ferrand, Department of Psychiatry, University of Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal (UMR 6602), Clermont-Ferrand, France

2. GHU Paris – Psychiatry and Neurosciences, Clinique des maladies mentales et de l’encéphale, Sainte-Anne Hospital, Paris, France

3. Department of Psychiatry, CH Ste Anne, Paris, France

4. Movement, Interactions, Performance, MIP, Nantes Université, CHU Nantes, Nantes, France UR

5. Medical Affairs, Janssen Cilag, Issy-les-Moulineaux, France

6. University Department of Psychiatry, Therapeutic Centre of Excellence, Institute of Psychiatry – Rouvray Hospital Centre, Sotteville-lès-Rouen, France

Funder

Lundbeck

Otsuka

Esaï and Ethypharm

Janssen-Cilag

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13651501.2024.2398788

Reference39 articles.

1. American Psychiatric Association. (2000). Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th ed., vol. vii, p. 943). American Psychiatric Association.

2. Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental

3. Acceptability, attitudes and knowledge towards Transcranial Magnetic Stimulation (TMS) among psychiatrists in France

4. Safety and effectiveness of intranasal esketamine for treatment-resistant depression: a real-world retrospective study

5. Current and Common Definitions of Treatment-Resistant Depression: Findings from a Systematic Review and Qualitative Interviews